Use of macrophage colony-stimulating factor in the treatment of fungal infections

Area of Science:

• Immunology
• Infectious Diseases
• Medical Mycology

Background:

• Fungal infections present a major medical challenge, with increased risk in immunocompromised patients, those undergoing intensive therapy, or with invasive devices.
• High morbidity and mortality rates are associated with fungal infections, particularly in transplant recipients.
• Cytokines enhancing immune cell function are being investigated for their therapeutic potential.

Purpose of the Study:

• To investigate the efficacy of macrophage colony-stimulating factor (M-CSF) in managing fungal infections.
• To evaluate M-CSF's role in improving outcomes for high-risk patient populations.

Main Methods:

• Review of animal models and clinical data assessing M-CSF's impact on fungal infections.
• Analysis of M-CSF's effects on monocyte and macrophage functions, including cytotoxicity and phagocytosis.

Main Results:

• M-CSF enhances critical immune cell functions: cytotoxicity, superoxide production, phagocytosis, chemotaxis, and secondary cytokine production.
• Animal studies and clinical data indicate M-CSF's effectiveness in controlling fungal infections.

Conclusions:

• Macrophage colony-stimulating factor (M-CSF) demonstrates potential as a therapeutic agent for fungal infections.
• M-CSF may improve survival rates in patients at high risk for severe fungal infections.